Cargando…
Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
BACKGROUND: Our study aimed to compare real-world healthcare resource utilization (HRU) and healthcare cost (HC) of Medicare-insured patients (≥65 years old) with Dupuytren’s contracture (DC) treated with Clostridium histolyticum (collagenase) or fasciectomy. METHODS: DC patients treated with collag...
Autores principales: | Zah, Vladimir, Stanicic, Filip, Ruby, Jane, Vukicevic, Djurdja, Hurley, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390814/ https://www.ncbi.nlm.nih.gov/pubmed/35999874 http://dx.doi.org/10.1097/GOX.0000000000004480 |
Ejemplares similares
-
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
por: Zah, Vladimir, et al.
Publicado: (2020) -
Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015) -
Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy
por: Divino, Victoria M., et al.
Publicado: (2020) -
Dupuytren’s Fasciectomy: Surgical Pearls in Planning and Dissection
por: Hever, Pennylouise, et al.
Publicado: (2020) -
Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study
por: Atroshi, Isam, et al.
Publicado: (2014)